Home › Employers › NeuWave Medical Inc.
NeuWave Medical Inc.: H-1B salaries and sponsorship
NeuWave Medical Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $140,000.
Does NeuWave Medical Inc. sponsor H-1B visas?
NeuWave Medical Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on May 18, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Staff Quality Engineer | 1 | $150,700 |
| Sr. Verification Engineer | 1 | $140,000 |
| Verification Engineer II | 1 | $115,000 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2025 | 1 | $150,700 |
| FY2026 | 2 | $127,500 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
- Mechanical Engineers1
- Software Quality Assurance Analysts and Testers1
- Bioengineers and Biomedical Engineers1
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Verification Engineer II | $115,000 Level II | Madison, WI | May 18, 2026 | Oct 1, 2026 | Certified |
| Sr. Verification Engineer | $140,000 Level IV | Madison, WI | Apr 28, 2026 | May 4, 2026 | Certified |
| Staff Quality Engineer | $150,700 Level IV | Madison, WI | Mar 5, 2025 | Apr 11, 2025 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).